Skip to main content
. 2017 May 24;8:15159. doi: 10.1038/ncomms15159

Figure 4. Efficacy of E209 in the in vivo-humanized SCID mouse model of P. falciparum.

Figure 4

(a) Parasitemia in peripheral blood of NSG mice infected with the P. falciparum strain 3D70087/N9 (n=2 mice treated with vehicle and n=6 mice treated with E209). (b) Blood levels of E209 in the efficacy experiment shown in a over the first 24 h post-dosing. (c) dose/exposure–response relationship.